{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:41:06Z","timestamp":1775194866924,"version":"3.50.1"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":285,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Aging Brain"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.nbas.2021.100024","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T12:21:44Z","timestamp":1636374104000},"page":"100024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?"],"prefix":"10.1016","volume":"1","author":[{"given":"Alexios-Fotios A.","family":"Mentis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia M.","family":"Bougea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbas.2021.100024_b0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-12-819973-2.00019-8","article-title":"Hypothalamic symptoms of frontotemporal dementia disorders","volume":"182","author":"Ahmed","year":"2021","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2018.23","article-title":"Physiological changes in neurodegeneration - mechanistic insights and clinical utility","volume":"14","author":"Ahmed","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/acn3.721","article-title":"Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"6","author":"Ahmed","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nbas.2021.100024_b0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-0-12-820107-7.00020-3","article-title":"Hypothalamus and weight loss in amyotrophic lateral sclerosis","volume":"180","author":"Ahmed","year":"2021","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"10.1016\/j.nbas.2021.100024_b0025","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","article-title":"Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study","volume":"13","author":"Al-Chalabi","year":"2014","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","article-title":"Gene discovery in amyotrophic lateral sclerosis: implications for clinical management","volume":"13","author":"Al-Chalabi","year":"2017","journal-title":"Nature Reviews Neurology"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0035","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1210\/jc.2004-1667","article-title":"Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications","volume":"90","author":"Alesci","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0040","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jcsm.12422","article-title":"Histaminergic transmission slows progression of amyotrophic lateral sclerosis","volume":"10","author":"Apolloni","year":"2019","journal-title":"Journal of cachexia, sarcopenia and muscle"},{"key":"10.1016\/j.nbas.2021.100024_b0045","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3389\/fimmu.2017.01689","article-title":"Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis","volume":"8","author":"Apolloni","year":"2017","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.nbas.2021.100024_b0050","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1172\/JCI124481","article-title":"TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets","volume":"129","author":"Araki","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nbas.2021.100024_b0055","doi-asserted-by":"crossref","unstructured":"Arthur, K.C., Calvo, A., Price, T.R., Geiger, J.T., Chi\u00f2, A., Traynor, B.J., 2016. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun 7, 12408-12408.","DOI":"10.1038\/ncomms12408"},{"key":"10.1016\/j.nbas.2021.100024_b0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58565","article-title":"Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in Drosophila","volume":"10","author":"Atilano","year":"2021","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.25431","article-title":"Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis","volume":"85","author":"Bandres-Ciga","year":"2019","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40035-021-00241-6","article-title":"Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients","volume":"10","author":"Bayer","year":"2021","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endo.138.1.4835","article-title":"Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro","volume":"138","author":"Behl","year":"1997","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000443146","article-title":"Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies","volume":"46","author":"Belbasis","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0085","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1471-4159.2010.06753.x","article-title":"Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice","volume":"114","author":"Bergemalm","year":"2010","journal-title":"J Neurochem"},{"issue":"12","key":"10.1016\/j.nbas.2021.100024_b0090","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/mp.2014.178","article-title":"Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques","volume":"20","author":"Bethea","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"15","key":"10.1016\/j.nbas.2021.100024_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157781","article-title":"TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia","volume":"22","author":"Bright","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotrophic lateral sclerosis and other motor neuron disorders"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/17482968.2011.643899","article-title":"SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experience","volume":"13","author":"Brown","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0110","first-page":"631","article-title":"Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders","volume":"5","author":"Cameron","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.nbas.2021.100024_b0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000445154","article-title":"Exercise, Training, and the Hypothalamic-Pituitary-Gonadal Axis in Men and Women","volume":"47","author":"Cano Sokoloff","year":"2016","journal-title":"Front Horm Res"},{"key":"10.1016\/j.nbas.2021.100024_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.599216","article-title":"Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis","volume":"11","author":"Caplliure-Llopis","year":"2020","journal-title":"Front Neurol"},{"issue":"18","key":"10.1016\/j.nbas.2021.100024_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184388","article-title":"Gene Therapy for ALS-A Perspective","volume":"20","author":"Cappella","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1590\/S0004-282X2005000100029","article-title":"Primary hyperparathyroidism simulating motor neuron disease: case report","volume":"63","author":"Carvalho","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.nbas.2021.100024_b0135","doi-asserted-by":"crossref","first-page":"2105607","DOI":"10.1155\/2019\/2105607","article-title":"Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View","volume":"2019","author":"Cenini","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3757","article-title":"Heat-shock protein dysregulation is associated with functional and pathological TDP-43 aggregation","volume":"4","author":"Chang","year":"2013","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1750-1326-8-28","article-title":"Genetics of amyotrophic lateral sclerosis: an update","volume":"8","author":"Chen","year":"2013","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications","volume":"17","author":"Chia","year":"2018","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature","volume":"41","author":"Chi\u00f2","year":"2013","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0160","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-8529(18)30191-9","article-title":"Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective","volume":"21","author":"Chrousos","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"20","key":"10.1016\/j.nbas.2021.100024_b0165","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1210\/endo.139.2.5857","article-title":"Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity\u2013a dynamic digital-to-analog modulation","volume":"139","author":"Chrousos","year":"1998","journal-title":"Endocrinology"},{"issue":"Suppl 2","key":"10.1016\/j.nbas.2021.100024_b0175","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/sj.ijo.0801278","article-title":"The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes","volume":"24","author":"Chrousos","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"8","key":"10.1016\/j.nbas.2021.100024_b0180","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4103\/1673-5374.162690","article-title":"The neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis","volume":"10","author":"Chung","year":"2015","journal-title":"Neural Regen Res"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/mp.54.6.386","article-title":"Mechanisms of neurodegeneration in amyotrophic lateral sclerosis","volume":"54","author":"Cluskey","year":"2001","journal-title":"Mol Pathol"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(14)70221-2","article-title":"End-of-life management in patients with amyotrophic lateral sclerosis","volume":"14","author":"Connolly","year":"2015","journal-title":"Lancet Neurol"},{"issue":"24","key":"10.1016\/j.nbas.2021.100024_b0195","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1093\/hmg\/ddy310","article-title":"Loss of LDAH associated with prostate cancer and hearing loss","volume":"27","author":"Currall","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0200","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/CPJ.0000000000000521","article-title":"Body mass index and survival from amyotrophic lateral sclerosis: A meta-analysis","volume":"8","author":"Dardiotis","year":"2018","journal-title":"Neurol Clin Pract"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062137","article-title":"Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases","volume":"21","author":"De Nicola","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-020-02216-9","article-title":"Dipeptide repeat protein and TDP-43 pathology along the hypothalamic\u2013pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases","volume":"140","author":"Dedeene","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.nbas.2021.100024_b0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000477126","article-title":"Epidemiology of Amyotrophic Lateral Sclerosis in the Republic of Cyprus: A 25-Year Retrospective Study","volume":"48","author":"Demetriou","year":"2017","journal-title":"Neuroepidemiology"},{"issue":"7363","key":"10.1016\/j.nbas.2021.100024_b0225","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.nbas.2021.100024_b0230","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1073\/pnas.0602046103","article-title":"Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria","volume":"103","author":"Deng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.nbas.2021.100024_b0235","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/aje\/kwx176","article-title":"Blood lead, bone turnover, and survival in amyotrophic lateral sclerosis","volume":"186","author":"Fang","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bj.2018.03.004","article-title":"Salivary biomarkers for the diagnosis and monitoring of neurological diseases","volume":"41","author":"Farah","year":"2018","journal-title":"Biomed J"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0245","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949129","article-title":"IGF 1R regulates retrograde axonal transport of signalling endosomes in motor neurons","volume":"21","author":"Fellows","year":"2020","journal-title":"EMBO Rep"},{"issue":"24","key":"10.1016\/j.nbas.2021.100024_b0250","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1093\/hmg\/ddp460","article-title":"Defective autophagy in neurons and astrocytes from mice deficient in PI (3, 5) P2","volume":"18","author":"Ferguson","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0255","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/156720511795563700","article-title":"FTD and ALS: a tale of two diseases","volume":"8","author":"Ferrari","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.nbas.2021.100024_b0260","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12709","article-title":"Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis","author":"Gabery","year":"2021","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"10.1016\/j.nbas.2021.100024_b0265","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0b013e3182840689","article-title":"Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort","volume":"80","author":"Gallo","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0270","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0034-1371891","article-title":"Circulating gonadal and adrenal steroids in amyotrophic lateral sclerosis: possible markers of susceptibility and outcome","volume":"46","author":"Gargiulo-Monachelli","year":"2014","journal-title":"Horm Metab Res"},{"issue":"Pt B","key":"10.1016\/j.nbas.2021.100024_b0275","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neubiorev.2016.06.003","article-title":"Life stress, glucocorticoid signaling, and the aging epigenome: Implications for aging-related diseases","volume":"74","author":"Gassen","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"10.1016\/j.nbas.2021.100024_b0280","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1212\/WNL.0000000000002988","article-title":"Diagnostic criteria in amyotrophic lateral sclerosis: A multicenter prospective study","volume":"87","author":"Geevasinga","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0285","first-page":"85","article-title":"Amyotrophic lateral sclerosis mimic syndromes","volume":"15","author":"Ghasemi","year":"2016","journal-title":"Iran J Neurol"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0290","doi-asserted-by":"crossref","first-page":"868","DOI":"10.18632\/aging.101450","article-title":"Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging","volume":"10","author":"Gonos","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"10.1016\/j.nbas.2021.100024_b0295","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1210\/en.2016-1244","article-title":"Steroid profiling in male wobbler mouse, a model of amyotrophic lateral sclerosis","volume":"157","author":"Gonzalez Deniselle","year":"2016","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.nbas.2021.100024_b0300","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/jnnp-2017-315795","article-title":"Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis","volume":"88","author":"Gorges","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-510X(72)90089-5","article-title":"Abnormal insulin secretion in amyotrophic lateral sclerosis","volume":"16","author":"Goto","year":"1972","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nbas.2021.100024_b0310","first-page":"1","article-title":"Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1G93A astrocytes","author":"Granatiero","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2004.06.024","article-title":"Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS","volume":"1021","author":"Groeneveld","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.nbas.2021.100024_b0320","article-title":"Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress","author":"Halloran","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0325","first-page":"1","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.nbas.2021.100024_b0330","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/jnnp.2011.244939","article-title":"Population based epidemiology of amyotrophic lateral sclerosis using capture\u2013recapture methodology","volume":"82","author":"Huisman","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0335","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/WNL.50.6.1795","article-title":"Primary hyperparathyroidism and ALS: is there a relation?","volume":"50","author":"Jackson","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbas.2021.100024_b0340","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40035-015-0037-x","article-title":"Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis","volume":"4","author":"Jiang","year":"2015","journal-title":"Transl Neurodegener"},{"issue":"11","key":"10.1016\/j.nbas.2021.100024_b0345","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archneur.1982.00510230047014","article-title":"Response of patients with amyotrophic lateral sclerosis to testosterone therapy: endocrine evaluation","volume":"39","author":"Jones","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nbas.2021.100024_b0350","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fneur.2020.00363","article-title":"Low 25OH vitamin D blood levels are independently associated with higher amyotrophic lateral sclerosis severity scores: results from a prospective study","volume":"11","author":"Juntas-Morales","year":"2020","journal-title":"Front Neurol"},{"issue":"12","key":"10.1016\/j.nbas.2021.100024_b0355","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/hmg\/ddt080","article-title":"Investigating the contribution of VAPB\/ALS8 loss of function in amyotrophic lateral sclerosis","volume":"22","author":"Kabashi","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.nbas.2021.100024_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083875","article-title":"The Links between ALS and NF-\u03baB","volume":"22","author":"K\u00e4llstig","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5\u20136","key":"10.1016\/j.nbas.2021.100024_b0365","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/21678421.2013.780622","article-title":"Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"14","author":"Kandinov","year":"2013","journal-title":"Amyotrophic Lateral Scl Frontotemporal Degeneration"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0370","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3940(91)90560-G","article-title":"Calcitonin gene-related peptide immunoreactivity in familial amyotrophic lateral sclerosis","volume":"133","author":"Kato","year":"1991","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0375","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF00308816","article-title":"Calcitonin gene-related peptide immunoreactivity in spinal spheroids in motor neuron disease","volume":"82","author":"Kato","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"7\u20138","key":"10.1016\/j.nbas.2021.100024_b0380","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.mad.2010.05.003","article-title":"Mitochondrial dysfunction and intracellular calcium dysregulation in ALS","volume":"131","author":"Kawamata","year":"2010","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0385","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp-2011-301883","article-title":"Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion","volume":"83","author":"Khan","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0390","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archneur.1982.00510160047010","article-title":"Thyroid function in 44 patients with amyotrophic lateral sclerosis","volume":"39","author":"Kiessling","year":"1982","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.nbas.2021.100024_b0395","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaneurol.2015.0910","article-title":"Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study","volume":"72","author":"Kioumourtzoglou","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nbas.2021.100024_b0400","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fneur.2019.00191","article-title":"Biomarkers of metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Kirk","year":"2019","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006680","article-title":"Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases","volume":"13","author":"Kline","year":"2017","journal-title":"PLoS Genet"},{"issue":"5\u20136","key":"10.1016\/j.nbas.2021.100024_b0410","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/21678421.2018.1452946","article-title":"Structural and functional properties of bone are compromised in amyotrophic lateral sclerosis mice","volume":"19","author":"Ko","year":"2018","journal-title":"Amyotrophic Lateral Scl Frontotemporal Degeneration"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0415","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041065","article-title":"Altered mitochondrial dynamics in motor neuron disease: an emerging perspective","volume":"9","author":"Kodavati","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0420","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(02)00696-7","article-title":"Disruption of dynein\/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration","volume":"34","author":"LaMonte","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbas.2021.100024_b0425","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fneur.2020.00697","article-title":"Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis","volume":"11","author":"Lanznaster","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.nbas.2021.100024_b0430","doi-asserted-by":"crossref","first-page":"140.e141","DOI":"10.1016\/j.neurobiolaging.2019.10.024","article-title":"Serum 25-hydroxyvitamin D in amyotrophic lateral sclerosis: Mendelian randomization study","volume":"87","author":"Larsson","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0435","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1759720X13510479","article-title":"Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases","volume":"6","author":"Lewiecki","year":"2014","journal-title":"Therap Adv Musculosk Dis"},{"issue":"30","key":"10.1016\/j.nbas.2021.100024_b0440","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1073\/pnas.1008227107","article-title":"ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS\/TLS","volume":"107","author":"Ling","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nbas.2021.100024_b0445","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.3389\/fimmu.2018.02647","article-title":"ALS-Associated E478G Mutation in Human OPTN (Optineurin) Promotes Inflammation and Induces Neuronal Cell Death","volume":"9","author":"Liu","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0450","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s13760-017-0798-3","article-title":"CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis","volume":"117","author":"Mart\u00ednez","year":"2017","journal-title":"Acta Neurol Belg"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0455","first-page":"1690","article-title":"Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans","volume":"77","author":"Mastorakos","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nbas.2021.100024_b0460","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1749-6632.1995.tb44700.x","article-title":"Effects of the immune\/inflammatory reaction on the hypothalamic-pituitary-adrenal axis","volume":"771","author":"Mastorakos","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0465","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pmr.2012.06.011","article-title":"Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases","volume":"23","author":"McDonald","year":"2012","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"3\u20134","key":"10.1016\/j.nbas.2021.100024_b0470","first-page":"873","article-title":"Glucocorticoids may enhance oxygen radical-mediated neurotoxicity","volume":"17","author":"McIntosh","year":"1996","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0475","first-page":"848","article-title":"Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function","volume":"79","author":"Michelson","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nbas.2021.100024_b0480","doi-asserted-by":"crossref","DOI":"10.1002\/mus.27339","article-title":"Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients","author":"Milligan","year":"2021","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0485","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JND-170281","article-title":"The Utility of the Laboratory Work Up at the Time of Diagnosis of Amyotrophic Lateral Sclerosis","volume":"5","author":"Mirian","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0490","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40478-020-00943-4","article-title":"Transmission of ALS pathogenesis by the cerebrospinal fluid","volume":"8","author":"Mishra","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0495","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/NRL.0b013e3181b46fef","article-title":"Rapid progression of amyotrophic lateral sclerosis in an acromegalic patient after surgical resection of a growth hormone-producing pituitary adenoma","volume":"16","author":"Mondok","year":"2010","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0500","doi-asserted-by":"crossref","first-page":"9968","DOI":"10.1038\/s41598-019-46355-w","article-title":"Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS","volume":"9","author":"Morello","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0505","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2006.02609.x","article-title":"Growth hormone secretion is impaired in amyotrophic lateral sclerosis","volume":"65","author":"Morselli","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.nbas.2021.100024_b0510","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/bph.12476","article-title":"Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?","volume":"171","author":"Muyderman","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0515","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0009-8981(72)90061-7","article-title":"Tyrosine hydroxylase in human adrenal glands and human pheochromocytoma","volume":"39","author":"Nagatsu","year":"1972","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0520","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1038\/s41598-017-04706-5","article-title":"Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis - results from a population- based ALS registry in Germany","volume":"7","author":"Nagel","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0525","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41598-020-57744-x","article-title":"Association of Insulin-like Growth Factor 1 Concentrations with Risk for and Prognosis of Amyotrophic Lateral Sclerosis - Results from the ALS Registry Swabia","volume":"10","author":"Nagel","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0530","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40478-020-01018-0","article-title":"Defining novel functions for cerebrospinal fluid in ALS pathophysiology","volume":"8","author":"Ng Kee Kwong","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"10.1016\/j.nbas.2021.100024_b0535","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12938","article-title":"Ghrelin as a treatment for amyotrophic lateral sclerosis","volume":"33","author":"Ngo","year":"2021","journal-title":"J Neuroendocrinol"},{"issue":"11","key":"10.1016\/j.nbas.2021.100024_b0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112616","article-title":"Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis","volume":"20","author":"Nowicka","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0545","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/neup.12139","article-title":"Cytoplasmic TDP-43 accumulation in cells of the adrenal medulla in individuals with or without amyotrophic lateral sclerosis","volume":"34","author":"Okamoto","year":"2014","journal-title":"Neuropathology"},{"issue":"1\u20132","key":"10.1016\/j.nbas.2021.100024_b0550","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3940(93)90576-7","article-title":"Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum","volume":"162","author":"Okamoto","year":"1993","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0555","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/humu.23697","article-title":"New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis","volume":"40","author":"Pampalakis","year":"2019","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0560","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/187152412800229152","article-title":"Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy","volume":"12","author":"Pandya","year":"2012","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"12","key":"10.1016\/j.nbas.2021.100024_b0565","doi-asserted-by":"crossref","first-page":"Rc23-25","DOI":"10.1007\/BF03349149","article-title":"Adrenal dysregulation in amyotrophic lateral sclerosis","volume":"26","author":"Patacchioli","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.nbas.2021.100024_b0570","first-page":"181","article-title":"Phosphate and parathyroid disorders associated with the syndrome of amyotrophic lateral sclerosis","volume":"36","author":"Patten","year":"1982","journal-title":"Adv Neurol"},{"key":"10.1016\/j.nbas.2021.100024_b0575","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mcn.2013.10.002","article-title":"UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"57","author":"Peixoto","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nbas.2021.100024_b0580","doi-asserted-by":"crossref","unstructured":"Perrone, F., Nguyen, H.P., Van Mossevelde, S., Moisse, M., Sieben, A., Santens, P., et al., 2017. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients. Neurobiol Aging 51, 177 e179-177 e116.","DOI":"10.1016\/j.neurobiolaging.2016.12.008"},{"issue":"245","key":"10.1016\/j.nbas.2021.100024_b0585","first-page":"pt6","article-title":"Posttraumatic stress disorder in children and adolescents: neuroendocrine perspectives","volume":"5","author":"Pervanidou","year":"2012","journal-title":"Sci Signal"},{"key":"10.1016\/j.nbas.2021.100024_b0590","doi-asserted-by":"crossref","unstructured":"Philips, T., Rothstein, J.D., 2015. Rodent Models of Amyotrophic Lateral Sclerosis. Curr Protoc Pharmacol 69, 5 67 61-65 67 21.","DOI":"10.1002\/0471141755.ph0567s69"},{"key":"10.1016\/j.nbas.2021.100024_b0595","doi-asserted-by":"crossref","unstructured":"Pineda, S.S., Lee, H., Fitzwalter, B.E., Mohammadi, S., Pregent, L.J., Gardashli, M.E., Mantero, J., Engelberg-Cook, E., DeJesus-Hernandez, M., van Blitterswijk, M., 2021. Single-cell profiling of the human primary motor cortex in ALS and FTLD. bioRxiv.","DOI":"10.1101\/2021.07.07.451374"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0600","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0196-9781(01)00638-6","article-title":"Calcitonin gene-related peptide-receptor component protein expression in the uterine cervix, lumbosacral spinal cord, and dorsal root ganglia","volume":"23","author":"Pokabla","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.nbas.2021.100024_b0605","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2019.01.026","article-title":"Interleukin-6 and amyotrophic lateral sclerosis","volume":"398","author":"Pronto-Laborinho","year":"2019","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0610","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00401-003-0777-z","article-title":"Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement","volume":"107","author":"Pullen","year":"2004","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archneur.1994.00540140057015","article-title":"Adrenal size is increased in multiple sclerosis","volume":"51","author":"Reder","year":"1994","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0620","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0625","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00018-016-2337-4","article-title":"Disruption of calcitonin gene-related peptide signaling accelerates muscle denervation and dampens cytotoxic neuroinflammation in SOD1 mutant mice","volume":"74","author":"Ringer","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0630","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.nbd.2011.09.011","article-title":"Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1\u2013G93A mouse model of amyotrophic lateral sclerosis","volume":"45","author":"Ringer","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nbas.2021.100024_b0635","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1752-1947-4-298","article-title":"Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature","volume":"4","author":"Rison","year":"2010","journal-title":"J Med Case Rep"},{"issue":"2","key":"10.1016\/j.nbas.2021.100024_b0640","first-page":"104","article-title":"Amyotrophic lateral sclerosis: its relationship with thyroid function and phosphate calcium metabolism","volume":"36","author":"Rodriguez","year":"2003","journal-title":"Rev Neurol"},{"issue":"24","key":"10.1016\/j.nbas.2021.100024_b0645","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1212\/WNL.0000000000004038","article-title":"Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease","volume":"88","author":"Rooney","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0650","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jamaneurol.2017.5129","article-title":"Association of serum retinol-binding protein 4 concentration with risk for and prognosis of amyotrophic lateral sclerosis","volume":"75","author":"Rosenbohm","year":"2018","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0655","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pmr.2008.03.001","article-title":"Nutrition and dietary supplements in motor neuron disease","volume":"19","author":"Rosenfeld","year":"2008","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.nbas.2021.100024_b0660","doi-asserted-by":"crossref","first-page":"154.e151","DOI":"10.1016\/j.neurobiolaging.2019.08.014","article-title":"C9ORF72 hexanucleotide repeat expansion frequency in patients with Paget's disease of bone","volume":"85","author":"Rubino","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0665","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0670","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00415-011-6146-2","article-title":"A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results","volume":"259","author":"Sacc\u00e0","year":"2012","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0675","first-page":"225","article-title":"Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis","volume":"37","author":"Sato","year":"1997","journal-title":"Eur Neurol"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0680","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10040245","article-title":"Salivary biomarkers: future approaches for early diagnosis of neurodegenerative diseases","volume":"10","author":"Schepici","year":"2020","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0685","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yfrne.2011.10.001","article-title":"Estrogen neuroprotection and the critical period hypothesis","volume":"33","author":"Scott","year":"2012","journal-title":"Front Neuroendocrinol"},{"issue":"8","key":"10.1016\/j.nbas.2021.100024_b0690","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s10072-021-05328-6","article-title":"Dysregulation of IGF-1\/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions","volume":"42","author":"Shandilya","year":"2021","journal-title":"Neurol Sci"},{"issue":"12","key":"10.1016\/j.nbas.2021.100024_b0695","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1212\/WNL.0000000000000254","article-title":"ALS2 mutations: juvenile amyotrophic lateral sclerosis and generalized dystonia","volume":"82","author":"Sheerin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nbas.2021.100024_b0700","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1911956116","article-title":"IgGs from patients with amyotrophic lateral sclerosis and diabetes target CaValpha2delta1 subunits impairing islet cell function and survival","author":"Shi","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nbas.2021.100024_b0705","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.expneurol.2018.06.009","article-title":"Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis","volume":"307","author":"Shijo","year":"2018","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0710","first-page":"209","article-title":"Rank\/Rankl\/opg: literature review","volume":"36","author":"Silva","year":"2011","journal-title":"Acta Reumatol Portuguesa"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0715","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/aian.AIAN_491_17","article-title":"Clinical mimickers of amyotrophic lateral sclerosis-conditions we cannot afford to miss","volume":"21","author":"Singh","year":"2018","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.nbas.2021.100024_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0725","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/mus.880160608","article-title":"Recombinant growth hormone treatment of amyotrophic lateral sclerosis","volume":"16","author":"Smith","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbas.2021.100024_b0730","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fphys.2021.659977","article-title":"Biological Functions of RBP4 and its relevance for human diseases","volume":"12","author":"Steinhoff","year":"2021","journal-title":"Front Physiol"},{"issue":"12","key":"10.1016\/j.nbas.2021.100024_b0735","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1210\/en.2013-1570","article-title":"Growth hormone secretion is correlated with neuromuscular innervation rather than motor neuron number in early-symptomatic male amyotrophic lateral sclerosis mice","volume":"154","author":"Steyn","year":"2013","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0740","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1038\/s41598-018-22318-5","article-title":"Metabolic Reprogramming in Amyotrophic Lateral Sclerosis","volume":"8","author":"Szelechowski","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0745","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ajhg.2013.09.008","article-title":"ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19","volume":"93","author":"Takahashi","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.nbas.2021.100024_b0750","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1007\/s00415-018-8983-8","article-title":"Amyotrophic lateral sclerosis: the complex path to precision medicine","volume":"265","author":"Talbot","year":"2018","journal-title":"J Neurol"},{"issue":"7628","key":"10.1016\/j.nbas.2021.100024_b0755","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0760","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-013-1090-0","article-title":"Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology","volume":"125","author":"Teyssou","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0765","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00001756-200103260-00025","article-title":"The expression of calcitonin gene-related peptide in dorsal horn neurons of the mouse lumbar spinal cord","volume":"12","author":"Tie-Jun","year":"2001","journal-title":"NeuroReport"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0770","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/1529-0131(200004)43:4<872::AID-ANR19>3.0.CO;2-T","article-title":"Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia","volume":"43","author":"Torpy","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0775","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41430-019-0448-3","article-title":"Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS)","volume":"74","author":"Trojsi","year":"2020","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0780","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0889-8529(18)30078-1","article-title":"Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders","volume":"23","author":"Tsigos","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0785","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J Psychosom Res"},{"issue":"11","key":"10.1016\/j.nbas.2021.100024_b0790","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112818","article-title":"Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques","volume":"20","author":"van den Bos","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.nbas.2021.100024_b0795","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","article-title":"Energy metabolism in ALS: an underappreciated opportunity?","volume":"135","author":"Vandoorne","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"Pt 4","key":"10.1016\/j.nbas.2021.100024_b0800","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/brain\/aww004","article-title":"Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis","volume":"139","author":"Vercruysse","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.nbas.2021.100024_b0805","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fnmol.2018.00002","article-title":"Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism","volume":"11","author":"Vercruysse","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.nbas.2021.100024_b0810","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13311-016-0503-x","article-title":"Fluid-based biomarkers for amyotrophic lateral sclerosis","volume":"14","author":"Vu","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.nbas.2021.100024_b0815","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1980.00500520027002","article-title":"Possible role of androgen receptors in amyotrophic lateral sclerosis. A hypothesis","volume":"37","author":"Weiner","year":"1980","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0820","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","article-title":"Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model","volume":"17","author":"Westeneng","year":"2018","journal-title":"Lancet Neurol"},{"issue":"9934","key":"10.1016\/j.nbas.2021.100024_b0825","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","article-title":"Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"383","author":"Wills","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.nbas.2021.100024_b0830","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1101\/gad.9.17.2105","article-title":"Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse","volume":"9","author":"Winnier","year":"1995","journal-title":"Genes Dev"},{"issue":"3\u20134","key":"10.1016\/j.nbas.2021.100024_b0835","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/21678421.2020.1813310","article-title":"Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R(358)Ala variant groups in amyotrophic lateral sclerosis patients","volume":"22","author":"Wosiski-Kuhn","year":"2021","journal-title":"Amyotr Lateral Scl Frontotemporal Degeneration"},{"key":"10.1016\/j.nbas.2021.100024_b0840","doi-asserted-by":"crossref","first-page":"678","DOI":"10.12659\/MSM.908786","article-title":"Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)","volume":"24","author":"Yan","year":"2018","journal-title":"Med Sci Monit"},{"issue":"7","key":"10.1016\/j.nbas.2021.100024_b0845","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10072-014-1658-z","article-title":"An exploratory study of the association between thyroid hormone and survival of amyotrophic lateral sclerosis","volume":"35","author":"Zheng","year":"2014","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.nbas.2021.100024_b0850","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1210\/endo.133.6.8243274","article-title":"Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis","volume":"133","author":"Zhou","year":"1993","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.nbas.2021.100024_b0855","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11914-015-0281-0","article-title":"Muscle-bone crosstalk in amyotrophic lateral sclerosis","volume":"13","author":"Zhou","year":"2015","journal-title":"Curr Osteoporosis Rep"},{"issue":"13","key":"10.1016\/j.nbas.2021.100024_b0860","doi-asserted-by":"crossref","first-page":"8081","DOI":"10.1074\/jbc.M114.603985","article-title":"Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy","volume":"290","author":"Zhu","year":"2015","journal-title":"J Biol Chem"}],"updated-by":[{"DOI":"10.1016\/j.nbas.2022.100047","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["Aging Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958921000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958921000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:59:56Z","timestamp":1762905596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589958921000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":172,"alternative-id":["S2589958921000207"],"URL":"https:\/\/doi.org\/10.1016\/j.nbas.2021.100024","relation":{},"ISSN":["2589-9589"],"issn-type":[{"value":"2589-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?","name":"articletitle","label":"Article Title"},{"value":"Aging Brain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbas.2021.100024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100024"}}